LYEL(LYEL)
LYEL
ANALYST COVERAGE6 analysts
HOLD
▲ +162.9%upside to target
L $44.00
Med $45.00consensus
H $49.00Key MetricsTTM
Market Cap$399.48M
Revenue TTM$31.0K
Net Income TTM-$246.41M
Free Cash Flow-$134.42M
Gross Margin-7422.6%
Operating Margin-618909.7%
Net Margin-794858.1%
Return on Equity-85.7%
Return on Assets-70.3%
Debt / Equity0.14
Current Ratio7.23
EPS TTM$-11.26
PRICE
Prev Close
17.22
Open
16.95
Day Range16.14 – 17.37
16.14
17.37
52W Range7.65 – 45.00
7.65
45.00
25% of range
VOLUME & SIZE
Avg Volume
89.9K
FUNDAMENTALS
P/E Ratio
-1.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.57
High vol
TECHNICAL
RSI (14)
26
Oversold
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
LYEL News
About
No description available.
Crystal L. MackallFounder & Scientific Advisor
Stanley R. RiddellFounder & Scientific Advisor
Gary LeeChief Scientific Officer
Jarrad AguirreSenior Vice President of Medical Affairs
Lynn SeelyPrincipal Executive Officer, President, CEO & Director
Richard D. KlausnerFounder & Executive Chairman
Bryan SelbySenior Vice President of Clinical Development Operations
Mark A. MeltzGeneral Counsel & Corporate Secretary
Stephen J. HillChief Operating Officer
Ann TomlinChief Human Resources Officer
Smital ShahPrincipal Financial Officer, CFO & Chief Business Officer
Veronica Sanchez BulisVP, Corporate Controller, Principal Accounting Officer
Nellie DilleryDirector of Accounting